LORI L JONES
Social Work at John St, Seattle, WA

License number
Washington RN00121170
Category
Social Work
Type
Social Worker
License number
Washington RC00035141
Category
Social Work
Type
Social Worker
Address
Address
1600 E John St, Seattle, WA 98112
Phone
(206) 326-4530
(206) 326-4845 (Fax)
(509) 241-7349
(509) 241-7628 (Fax)

Personal information

See more information about LORI L JONES at radaris.com
Name
Address
Phone
Lori Jones
4561 Hanson Rd, Ellensburg, WA 98926
Lori Jones
4317 W Kathleen Ave, Spokane, WA 99208

Professional information

Lori Jones Photo 1

Resident Scientist At Seattle Cancer Care Alliance

Position:
Resident Scientist at Seattle Cancer Care Alliance
Location:
Greater Seattle Area
Industry:
Biotechnology
Work:
Seattle Cancer Care Alliance since 2009 - Resident Scientist Dendreon 1999 - 2008 - Sr Director Immunotherapy Development Northwest Biotherapeutics 1998 - 1999 - Scientist Targeted Genetics Corporation 1993 - 1998 - Staff Scientist
Education:
University of Kentucky 1983 - 1988
PhD, Immunology
Luther College 1979 - 1983
BA, Biology, Chemistry


Lori Jones Photo 2

Sr. Director Immunotherapy Development At Dendreon Corporation

Position:
Sr. Director Immunotherapy Development at Dendreon Corporation
Location:
Greater Seattle Area
Industry:
Biotechnology
Work:
Dendreon Corporation - Sr. Director Immunotherapy Development
Education:
University of Kentucky 1983 - 1988


Lori Jones Photo 3

Rn, Msw At Group Health Cooperative

Position:
RN, MSW at Group Health Cooperative
Location:
Greater Seattle Area
Industry:
Hospital & Health Care
Work:
Group Health Cooperative - RN, MSW
Education:
University of Washington 1996 - 1999


Lori L Jones Photo 4

Lori L Jones, Seattle WA

Specialties:
Social Work
Address:
1600 E John St, Seattle 98112
(206) 326-4530 (Phone), (206) 326-4845 (Fax)
Languages:
English


Lori Jones Photo 5

Promiscuous Her-2/Neu Cd4 T Cell Epitopes

US Patent:
2012030, Dec 6, 2012
Filed:
Aug 16, 2012
Appl. No.:
13/587619
Inventors:
Jami B. Wollan - Mountlake Terrace WA, US
Lori A. Jones - Seattle WA, US
Assignee:
Dendreon Corporation - Seattle WA
International Classification:
A61K 39/00, G01N 33/53, C12Q 1/02, C12N 5/10, C12N 1/21, C07H 21/04, C12N 15/63, A61K 38/00, A61K 38/10, A61P 37/00, C07K 7/08, A61K 38/19, C12N 1/19
US Classification:
424 851, 4241851, 435 792, 435 29, 435325, 435348, 4352523, 43525231, 43525233, 4352542, 4353201, 514 11, 514 214, 514 215, 530300, 530326, 530327, 536 231, 536 234
Abstract:
The present invention relates to the discovery of novel T cell epitopes of the human HER-2/Neu protein that is promiscuous for at least 25 different HLA-DR alleles. The invention also relates to compositions that contain one of the novel epitopes or a fusion peptide of such a epitope and a heterologous polypeptide. Further disclosed herein is the use of the epitopes or their fusion peptides, and compositions containing the epitopes or their fusion peptides.


Lori Jones Photo 6

Promiscuous Her-2/Neu Cd4 T Cell Epitopes

US Patent:
7972602, Jul 5, 2011
Filed:
Aug 9, 2007
Appl. No.:
11/836645
Inventors:
Jami B. Wollan - Mountlake Terrace WA, US
Lori A. Jones - Seattle WA, US
Assignee:
Dendreon Corporation - Seattle WA
International Classification:
A61K 39/00
US Classification:
4241851
Abstract:
The present invention relates to the discovery of novel T cell epitopes of the human HER-2/Neu protein that is promiscuous for at least 25 different HLA-DR alleles. The invention also relates to compositions that contain one of the novel epitopes or a fusion peptide of such a epitope and a heterologous polypeptide. Further disclosed herein is the use of the epitopes or their fusion peptides, and compositions containing the epitopes or their fusion peptides.


Lori Jones Photo 7

Promiscuous Pap Cd4 T Cell Epitopes

US Patent:
8647865, Feb 11, 2014
Filed:
Jan 4, 2013
Appl. No.:
13/734560
Inventors:
Lori A. Jones - Seattle WA, US
Assignee:
Dendreon Corporation - Seattle WA
International Classification:
C07H 21/02, C07H 21/04, C12N 15/00
US Classification:
4353201, 536 231, 536 234
Abstract:
The present invention relates to the discovery of novel T cell epitopes of the human prostatic acid phosphatase (PAP) protein that is promiscuous for at least 15 different HLA-DR alleles. The invention also relates to compositions that contain one of the novel epitopes or a fusion peptide of such an epitope and a heterologous polypeptide. Further disclosed herein is the use of the epitopes or their fusion peptides, and compositions containing the epitopes or their fusion peptides.


Lori Jones Photo 8

Promiscuous Her-2/Neu Cd4 T Cell Epitopes

US Patent:
8263757, Sep 11, 2012
Filed:
May 31, 2011
Appl. No.:
13/149408
Inventors:
Jami B. Wollan - Mountlake Terrace WA, US
Lori A. Jones - Seattle WA, US
Assignee:
Dendreon Corporation - Seattle WA
International Classification:
C07H 21/04, A61K 39/00
US Classification:
536 231, 536 234, 4241991
Abstract:
The present invention relates to the discovery of novel T cell epitopes of the human HER-2/Neu protein that is promiscuous for at least 25 different HLA-DR alleles. The invention also relates to compositions that contain one of the novel epitopes or a fusion peptide of such a epitope and a heterologous polypeptide. Further disclosed herein is the use of the epitopes or their fusion peptides, and compositions containing the epitopes or their fusion peptides.


Lori Jones Photo 9

Promiscuous Pap Cd4 T Cell Epitopes

US Patent:
8361479, Jan 29, 2013
Filed:
Aug 9, 2007
Appl. No.:
11/836653
Inventors:
Jami B. Wollan - Mountlake Terrace WA, US
Lori A. Jones - Seattle WA, US
Assignee:
Dendreon Corporation - Seattle WA
International Classification:
A61K 39/00, A61K 38/00, A61K 38/04, C07K 2/00, C07K 4/00, C07K 5/00, C07K 7/00, C07K 14/00, C07K 16/00, C07K 17/00
US Classification:
4241851, 4241921, 514 11, 530300, 530326
Abstract:
The present invention relates to the discovery of novel T cell epitopes of the human prostatic acid phosphatase (PAP) protein that is promiscuous for at least 15 different HLA-DR alleles. The invention also relates to compositions that contain one of the novel epitopes or a fusion peptide of such an epitope and a heterologous polypeptide. Further disclosed herein is the use of the epitopes or their fusion peptides, and compositions containing the epitopes or their fusion peptides.


Lori Jones Photo 10

Lori Jones

Location:
Greater Seattle Area
Industry:
Public Safety